3,854
Views
8
CrossRef citations to date
0
Altmetric
Research Article

Design, synthesis, and evaluation of novel 2-phenylpropionic acid derivatives as dual COX inhibitory-antibacterial agents

, , , , , , , & show all
Pages 732-745 | Received 20 Jan 2017, Accepted 15 Mar 2017, Published online: 16 Apr 2017

References

  • Gupta K, Selinsky BS, Kaub CJ, et al. The 2.0 Angstrom resolution crystal structure of prostaglandin H2 synthase-1: structural insights into an unusual peroxidase. J Mol Biol 2004;335:503–18.
  • Botting RM. Cyclooxygenase: past, present and future. Atribute to John R. Vane (1927–2004). J Therm Biol 2006;31:208–19.
  • Simmons DL, Botting RM, Hla T. Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition. Pharmacol Rev 2004;56:387–437.
  • Smith WL, Marnett LJ. Prostaglandin endoperoxide synthase: structure and catalysis. Biochim Biophys Acta 1991;1083:1–17.
  • Bakhle YS. Structure of COX-1 and COX-2 enzymes and their interaction with inhibitors. Drugs Today (Barc) 1999;35:237–50.
  • Smith WL, DeWitt DL, Garavito RM. Cyclooxygenases: structural, cellular, and molecular biology. Annu Rev Biochem 2000;69:145–82.
  • Garavito RM, Malkowski MG, DeWitt DL. The structures of prostaglandin endoperoxide H synthases-1 and -2. Prostaglandins Other Lipid Mediat 2002;68–69:129–52.
  • Picot D, Loll PJ, Garavito RM. The X-ray crystal structure of the membrane protein prostaglandin H2 synthase-1. Nature 1994;367:243–9.
  • Kurumbail RG, Stevens AM, Gierse JK, et al. Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents. Nature 1996;384:644–8.
  • Selinsky BS, Gupta K, Sharkey CT, Loll PJ. Structural analysis of NSAID binding by prostaglandin H2 synthase: time-dependent and time-independent inhibitors elicit identical enzyme conformations. Biochemistry 2001;40:5172–80.
  • Narayana B, Raj KKV, Ashalatha BV, Kumari NS. Synthesis of some new 2-(6-methoxy-2-naphthyl)- 5-aryl-1,3,4-oxadiazoles as possible non-steroidal anti-inflammatory and analgesic agents. Arch Pharm (Weinheim) 2005;338:373–7.
  • Borne R, Levi M, Wilson N. Nonsteroidal anti-inflammatory drugs (Chap. 31). In: Lemke TL, Williams DA, Roche VF, Zito SW, eds. Foye’s principles of medicinal chemistry, 7th ed. Philadelphia: Lippincott Williams & Wilkins; 2013:987–1044.
  • Downer-Riley NK, Jackson YA. Recent advances in the synthesis of 1,3-azoles. Curr Top Med Chem 2016;16:3617–26.
  • Peng XM, Cai GX, Zhou CH. Recent developments in azole compounds as antibacterial and antifungal agents. Curr Top Med Chem 2013;13:1963–2010.
  • Zhao S, Zhao L, Zhang X, et al. Design, synthesis, and structure-activity relationship studies of benzothiazole derivatives as antifungal agents. Eur J Med Chem 2016;123:514–22.
  • Vijesh AM, Isloor AM, Shetty P, et al. New pyrazole derivatives containing 1,2,4-triazoles and benzoxazoles as potent antimicrobial and analgesic agents. Eur J Med Chem 2013;62:410–5.
  • Moraca F, De Vita D, Pandolfi F, et al. Synthesis, biological evaluation and structure-activity correlation study of a series of imidazol-based compounds as Candida albicans inhibitors. Eur J Med Chem 2014;83:665–73.
  • Ansari KF, Lal C. Synthesis and evaluation of some new benzimidazole derivatives as potential antimicrobial agents. Eur J Med Chem 2009;44:2294–9.
  • Zhang HZ, Damu GL, Cai GX, Zhou CH. Design, synthesis and antimicrobial evaluation of novel benzimidazole type of fluconazole analogues and their synergistic effects with chloromycin, norfloxacin and fluconazole. Eur J Med Chem 2013;64:329–44.
  • Kant R, Kumar D, Agarwal D, et al. Synthesis of newer 1,2,3-triazole linked chalcone and flavone hybrid compounds and evaluation of their antimicrobial and cytotoxic activities. Eur J Med Chem 2016;113:34–49.
  • Morjan RY, Al-Attar NH, Abu-Teim OS, et al. Synthesis, antibacterial and QSAR evaluation of 5-oxo and 5-thio derivatives of 1,4-disubstituted tetrazoles. Bioorg Med Chem Lett 2015;25:4024–8.
  • Rostom SA, Ashour HM, El Razik HA, et al. Azole antimicrobial pharmacophore-based tetrazoles: synthesis and biological evaluation as potential antimicrobial and anticonvulsant agents. Bioorg Med Chem 2009;17:2410–22.
  • Secci D, Bolasco A, D'Ascenzio M, et al. Conventional and microwave‐assisted synthesis of benzimidazole derivatives and their in vitro inhibition of human cyclooxygenase. J Heterocyclic Chem 2012;49:1187–95.
  • Umaru T, Nwamba OC, Kolo I, Nwodo UU. Antimicrobial activity of non-steroidal anti-inflammatory drugs with respect to immunological response: diclofenac sodium as a case study. Afr J Biotechnol 2009;8:7332–9.
  • Weng TC, Chen CC, Toh HS, Tang HJ. Ibuprofen worsens Streptococcus pyogenes soft tissue infections in mice. J Microbiol Immunol Infect 2011;44:418–23.
  • Leroy S, Marc E, Bavoux F, et al. Hospitalization for severe bacterial infections in children after exposure to NSAIDs. A prospective adverse drug reaction reporting study. Clin Drug Invest 2010;30:179–85.
  • Bekhit AA, Abdel-Azeim T. Design, synthesis and biological evaluation of some pyrazole derivatives as anti-inflammatory-antimicrobial agents. Bioorg Med Chem 2004;12:1935–45.
  • Sharshira EM, Hamada NM. Synthesis and antimicrobial evaluation of some pyrazole derivatives. Molecules 2012;17:4962–71.
  • Handler N, Jaeger W, Kuen-Krismer B, Erker T. Cyclooxygenase-1 and cyclooxygenase-2 inhibition of novel 1,2-disubstituted imidazoles. Arch Pharm (Weinheim) 2005;338:602–4.
  • Parab RH, Dixit BC. Synthesis, characterization and antimicrobial activity of imidazole derivatives based on 2-chloro-7-methyl-3-formylquinoline. J Chem 2012;9:1188–95.
  • Ahmadi F, Ghayahbashi MR, Sharifzadeh M, et al. Synthesis and evaluation of anti-inflammatory and analgesic activities of new 1,2,4-triazole derivatives. Med Chem 2015;11:69–76.
  • Eswaran S, Adhikari AV, Shetty NS. Synthesis and antimicrobial activities of novel quinoline derivatives carrying 1,2,4-triazole moiety. Eur J Med Chem 2009;44:4637–47.
  • Deb PK, Kaur R, Chandrasekaran B, et al. Synthesis, anti-inflammatory evaluation, and docking studies of some new thiazole derivatives. Med Chem Res 2014;23:2780–92.
  • Bondock S, Khalifa W, Fadda AA. Synthesis and antimicrobial evaluation of some new thiazole, thiazolidinone and thiazoline derivatives starting from 1-chloro-3,4-dihydronaphthalene-2-carboxaldehyde. Eur J Med Chem 2007;42:948–54.
  • Alegaon SG, Hirpara MB, Alagawadi KR, et al. Synthesis of novel pyrazole–thiadiazole hybrid as potential potent and selective cyclooxygenase-2 (COX-2) inhibitors. Bioorg Med Chem Lett 2014;24:5324–9.
  • Bekhit AA, El-Sayed OA, Aboulmagd E, Park JY. Tetrazolo[1,5-a]quinoline as a potential promising new scaffold for the synthesis of novel anti-inflammatory and antibacterial agents. Eur J Med Chem 2004;39:249–55.
  • Parveen H, Mukhtar S, El Sayed NH, Hayat F. Synthesis, characterization and antimicrobial activity of long chain fatty alkenoates of metronidazole and their novel tetrazole derivatives. Asian J Chem 2014;26:8134–8.
  • Lu X, Zhang H, Li X, et al. Design, synthesis and biological evaluation of pyridine acyl sulfonamide derivatives as novel COX-2 inhibitors. Bioorg Med Chem 2011;19:6827–32.
  • Jyothi MV, Rajendra Prasad Y, Venkatesh P, Sureshreddy M. Synthesis and antimicrobial activity of some novel chalcones of 3-acetyl pyridine and their pyrimidine derivatives. Chem Sci Trans 2012;1:716–22.
  • Moneer AA, Mohammed KO, El-Nassan HB. Synthesis of novel substituted thiourea and benzimidazole derivatives containing a pyrazolone ring as anti-inflammatory agents. Chem Biol Drug Des 2016;87:784–93.
  • Altıntop MD, Abu Mohsen U, Özkay Y, et al. Synthesis and antimicrobial activity of benzimidazole-based acetamide derivatives. Turk J Pharm Sci 2015;12:29–38.
  • Paramashivappa R, Phani Kumar P, Subba Rao PV, Srinivasa Rao A. Design, synthesis and biological evaluation of benzimidazole/benzothiazole and benzoxazole derivatives as cyclooxygenase inhibitors. Bioorg Med Chem Lett 2003;13:657–60.
  • Ören İ, Temiz Ö, Yalçın İ, et al. Synthesis and antimicrobial activity of some novel 2,5- and/or 6-substituted benzoxazole and benzimidazole derivatives. Eur J Pharm Sci 1999;7:153–60.
  • Vázquez MT, Rosell G, Pujol MD. Synthesis and anti-inflammatory activity of rat-2-(2,3-dihydro-1,4-benzodioxin)propionic acid and its R and S enantiomers. Eur J Med Chem 1997;32:529–34.
  • Xingxian Z, Kebin H, Jiankun N, et al. Process for preparation of loxoprofen sodium, Patent CN 101412670, 2009.
  • Özkay Y, Işıkdağ İ, İncesu Z, et al. Synthesis of 2-substituted-N-[4-(1-methyl-4,5-diphenyl-1H-imidazole-2-yl)phenyl]acetamide derivatives and evaluation of their anticancer activity. Eur J Med Chem 2010;45:3320–8.
  • Biovision COX-1 Fluorescent Inhibitor Screening Kit (Catalog No: K548-100) manual. Available from: http://www.biovision.com/manuals/K548.pdf [last accessed Aug 2016].
  • Biovision COX-2 fluorescent inhibitor screening kit (Catalog No: K547-100) manual. Available from: http://www.biovision.com/manuals/K547.pdf [last accessed Aug 2016].
  • Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved Standard-Ninth Edition. Pennsylvania, USA: CLSI document M07-A9.
  • EUCAST. Definitive document EDef 7.1: method for the determination of broth dilution MICs of antifungal agents for fermentative yeasts. Copenhagen, Denmark: EUCAST.
  • Sağlık BN, Ilgın S, Özkay Y. Synthesis of new donepezil analogues and investigation of their effects on cholinesterase enzymes. Eur J Med Chem 2016;124:1026–40.
  • Demir Özkay Ü, Can ÖD, Sağlık BN, et al. Design, synthesis, and AChE inhibitory activity of new benzothiazole-piperazines. Bioorg Med Chem Lett 2016;26:5387–94.
  • Patel S, Gheewala N, Suthar A, Shah A. In-vitro cytotoxicity activity of Solanum nigrum extract against hela cell line and vero cell line. Int J Pharm Pharm Sci 2009;1:38–46.
  • Altıntop MD, Özdemir A, Turan-Zitouni G, et al. Synthesis and biological evaluation of some hydrazone derivatives as new anticandidal and anticancer agents. Eur J Med Chem 2012;58:299–307.
  • Chandrasekaran CV, Sundarajan K, Gupta A, et al. Evaluation of the genotoxic potential of standardized extract of Glycyrrhiza glabra (GutGard™). Regul Toxicol Pharmacol 2011;61:373–80.
  • Flückiger-Isler S, Kamber M. Direct comparison of the Ames microplate format (MPF) test in liquid medium with the standard Ames preincubation assay on agar plates by use of equivocal to weakly positive test compounds. Mutat Res 2012;747:36–45.
  • M. Cheminformatics, Bratislava, Slovak Republic. Available from: http://www.molinspiration.com/services/properties.html [last accessed Aug 2016].
  • Maestro, version 10.6. New York, NY: Schrödinger, LLC; 2016.
  • Schrödinger, LLC, New York, NY, 2016.
  • Kaserer T, Temml V, Kutil Z, et al. Prospective performance evaluation of selected common virtual screening tools. Case study: cyclooxygenase (COX) 1 and 2. Eur J Med Chem 2015;96:445–57.
  • LigPrep, version 3.8. New York, NY: Schrödinger, LLC; 2016.
  • Glide, version 7.1. New York, NY: Schrödinger, LLC; 2016.
  • Borra RC, Lotufo MA, Gagioti SM, et al. A simple method to measure cell viability in proliferation and cytotoxicity assays. Braz Oral Res 2009;23:255–62.
  • Palomino JC, Martin A, Camacho M, et al. Resazurin microtiter assay plate: simple and inexpensive method for detection of drug resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother 2002;46:2720–2.
  • Larina L, Lopyrev V. Nitroazoles: synthesis, structure and applications. New York: Springer Science, 2009.
  • Pozzolini M, Scarfı′ S, Benatti U, Giovine M. Interference in MTT cell viability assay in activated macrophage cell line. Anal Biochem 2003;313:338–41.
  • Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:55–63.
  • International Organization for Standardization. Biological evaluation of medical devices-part 5: tests for in vitro cytotoxicity ISO-10993-5. 3rd ed. Geneva, Switzerland: International Organization for Standardization; 2009.
  • Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 2001;46:3–26.